BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7668551)

  • 1. IL-6 is present in sera of bone marrow-transplanted patients in aplastic period and high levels of IL-6 during acute graft-versus-host disease are associated with severe gut symptoms.
    Karabon L; Moniewska A; Laba A; Swider C; Lange A
    Ann N Y Acad Sci; 1995 Jul; 762():439-42. PubMed ID: 7668551
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
    Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the severity of intestinal graft-versus-host disease from leukotriene B4 levels after bone marrow transplantation.
    Takatsuka H; Yamada S; Okamoto T; Fujimori Y; Wada H; Iwata N; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 2000 Dec; 26(12):1313-6. PubMed ID: 11223971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperacute graft-versus-host disease accompanied by increased serum interleukin-6 levels.
    Imamura M; Hashino S; Kobayashi S; Kobayashi H; Tanaka J; Imai K; Kasai M; Sakurada K; Miyazaki T
    Int J Hematol; 1994 Jul; 60(1):85-9. PubMed ID: 7919241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the severity of graft-versus-host disease from interleukin-10 levels after bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Yamada S; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Nov; 24(9):1005-7. PubMed ID: 10556960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.
    Ferrà C; de Sanjosé S; Gallardo D; Berlanga JJ; Rueda F; Marìn D; de la Banda E; Ancìn I; Peris J; Garcìa J; Grañena A
    Haematologica; 1998 Dec; 83(12):1082-7. PubMed ID: 9949625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum interleukin-6 levels during bone marrow transplantation: impact on transplant-related toxicity and engraftment.
    Steffen M; Dürken M; Pichlmeier U; von dem Busche C; Stockschläder M; Krüger W; Budde-Steffen C; Zander A
    Bone Marrow Transplant; 1996 Aug; 18(2):301-7. PubMed ID: 8864438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
    Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
    Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of serum cytokines after allogeneic bone marrow transplantation: interleukin-5 as a potential marker of acute graft-versus-host disease.
    Imoto S; Oomoto Y; Murata K; Das H; Murayama T; Kajimoto K; Sugimoto T; Gomyo H; Nakagawa T; Nishimura R; Koizumi T
    Int J Hematol; 2000 Jul; 72(1):92-7. PubMed ID: 10979216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation.
    Tong J; Viale M; Bacigalupo A; Podestà M; Sogno G; Tedone E; Marmont AM
    Haematologica; 1992; 77(4):365-6. PubMed ID: 1427449
    [No Abstract]   [Full Text] [Related]  

  • 11. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation.
    Schots R; Kaufman L; Van Riet I; Ben Othman T; De Waele M; Van Camp B; Demanet C
    Leukemia; 2003 Jun; 17(6):1150-6. PubMed ID: 12764383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation].
    Kai S; Shinohara Y; Ifuku H; Ohe Y; Misawa M; Noguchi K; Kohsaki M; Kanamaru A; Hara H; Nagai K
    Rinsho Ketsueki; 1985 Jan; 26(1):20-7. PubMed ID: 3889401
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.
    Chen YB; McDonough S; Chen H; Kennedy J; Illiano C; Attar EC; Ballen KK; Dey BR; McAfee SL; Jagasia M; Soiffer R; Spitzer TR; Ritz J
    Bone Marrow Transplant; 2013 Apr; 48(4):598-603. PubMed ID: 23042495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M
    Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased hepatocyte growth factor in serum in acute graft-versus-host disease.
    Okamoto T; Takatsuka H; Fujimori Y; Wada H; Iwasaki T; Kakishita E
    Bone Marrow Transplant; 2001 Jul; 28(2):197-200. PubMed ID: 11509938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo administration of interleukin-6 in murine allogeneic bone marrow chimeras: early and delayed enhancement of hematopoiesis accompanied with split tolerance but not with graft-versus-host disease.
    Imamura M; Hashino S; Kobayashi H; Tanaka J; Imai K; Han M; Fujii Y; Kobayashi M; Higa T; Kasai M
    Immunobiology; 1994 Jun; 190(4-5):346-67. PubMed ID: 7982720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Rowbottom AW; Riches PG; Downie C; Hobbs JR
    Bone Marrow Transplant; 1993 Dec; 12(6):635-41. PubMed ID: 8136747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute graft-versus-host disease: a clinical report and analysis of risk factors.
    Hong RL; Wang CH; Lin KH; Chen TL; Lin DT; Chen YC
    Taiwan Yi Xue Hui Za Zhi; 1989 Jul; 88(7):663-8. PubMed ID: 2809559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.